Near-Dead Cells to Special Tetraploidy to First Cells to Cancer Diagnostic Morphology: Unlikely Therapy-Gain from For-Profit Industrial Goliath — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Near-Dead Cells to Special Tetraploidy to First Cells to Cancer Diagnostic Morphology: Unlikely Therapy-Gain from For-Profit Industrial Goliath
The objective in this experimental article is to gain evidential proof of near-dead cells, (sick-cells in relapse tumor) responding with recovery growth from special 4n, multi-chromatid chromosomes. Note, near-dead normal human cells with such converted chromosome structure gave rise to proliferative, fitness-gained, diploid first cells , which further gave rise to three different cell shape changed, recovery growth patterns. Previously, two cell shape changes had been recovered from same type normal human cells, transiently exposed to amino acid glutamine deficient growth medium with recovery growths also associated with presence of the special 4n cells. The 4n cell-division had been concluded to be a meiotic-like two-step division system to the fitness-gained diploid cells in numerous experiments. The main characteristi cs of this division system, was firstly whole genomes without polar oriented bent centromeres moving apart followed by much rarer simple fission division to two or three diploid cells, selectable for first cell proliferatio n. In general these 4n cells showed metaphase type rosette figures moving apart not in the normal spindle associated mitotic shape with centromeres polar-pointing with sloping arms. This sequence of events induced by glutamine-deficiency, was earlier shown to cause DNA breakage in metabolic studies however, the near-death condition was only assumed from normal fibro-blastic cell-sheet shrinkage. This was rectified by an RNA virus (Coxakie-B3), which virology known is a highly cell killing virus (4+ CPE on their scale). This virus replicates only in replicating cells, which led to recovery growths with progressive phenotypic cell-shape changes (spindle, polygonal and roundness cells), each intervened by “total” cell destruction. These three different growth patterns had morphologies, indistinguishably from today’s cancer diagnostic morphologies. “Mitotic” analyses of beginning growths for the three phenotypes revealed the special rosette figure separations from special 4n and higher ploidy level cells, and also total absence of spindle type mitoses. Tumorigenesis-relevant was centromere-puffing with premature chromatid separation, and chromatin compaction, a mechanism, that was suggested to protect the genome from damage (text). We suggest that the multi-chromatid polyploid cells with their genome reductive division system, can be a tractable in vitro model system for therapy information, when repeated from a cell-killing agent, producing virus-free recovery growths. Will it be enacted upon? Not likely with profit-greedy industrial Goliath in the helm of cancer research. But, a not for profit cancer organization, could change this appalling situation.
KeywordsCytogeneticsAtavistic Activation
Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjoblom, T., Leary, R.J., et al. (2007) The Genomic Landscapes of Human Breast and Colorectal Cancer. Science, 318, 1108-1113. https://doi.org/10.1126/science.1145720
Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., et al. (2010) Accumulation of Driver and Passenger Mutations during Tumor Progression. Proceedings of the National Academy of Sciences of the United States of America, 107, 18545-18550. https://doi.org/10.1073/pnas.1010978107
Duesberg, P., Madrioli, D., McCormack, A. and Nicholson, J.M. (2011) Is Carcinogenesis a Form of Speciation? Cell Cycle, 10, 2100-2114. https://doi.org/10.4161/cc.10.13.16352
Vincent, M.D. (2009) The Animal Within: Carcinogenesis and Clonal Evolution of Cancer Cells Are Speciation Events Sensu Stricto. Evolution, 64, 1173-1183. https://doi.org/10.1111/j.1558-5646.2009.00942.x
Sonnenschein, C. and Soto, A.M. (2013) The Aging of the 2000 and 2011 Hallmarks of Cancer Reviews: A Critique. Journal of Biosciences, 38, 651-663. https://doi.org/10.1007/s12038-013-9335-6
Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epithelial-Mesenchymal Transition. The Journal of Clinical Investigation, 119, 1420-1428. https://doi.org/10.1172/JCI39104
Rohnalter, V., Roth, K., Finkernagel, F., Adhikary, T., Obert, J., Dorzweiler, K., et al. (2015) A Multi-Stage Process Including, Transient Polyploidization and EMT Precedes the Emergence of Chemoresistant Ovarian Carcinoma Cells with a Dedifferentiated and Pro-Inflammatory Secretory Phenotype. Oncotarget, 6, 40005-40025. https://doi.org/10.18632/oncotarget.5552
Liu, J. (2019) The “Life Code”: A Theory That Unifies the Human Life Cycle and the Origin of Human Tumors. Seminars in Cancer Biology, 60, 380-397. https://doi.org/10.1016/j.semcancer.2019.09.005
Walen, K.H. (2004) Spontaneous Cell Transformation: Karyoplasts Derived from Multi-Nucleated Cells Produce New Cell Growth in Senescent, Human Epithelial Cell Cultures. In Vitro Cellular & Developmental Biology: Animal, 40, 150-158. https://doi.org/10.1290/1543-706X(2004)40 2.0.CO;2
Walen, K.H. (2005) Budded Karyoplasts from Multinucleated Fibroblast Cells Contain Centrosomes and Change Their Morphology to Mitotic Cells. Cell Biology International, 29, 1057-1065. https://doi.org/10.1016/j.cellbi.2005.10.016
Walen, K.H. (2006) Human Diploid Fibroblast Cells in Senescence: Cycling from Polyploidy to Mitotic Cells. In Vitro Cellular & Developmental Biology: Animal, 42, 216-224. https://doi.org/10.1290/0603019.1
4n-Division-Perpendicularity
Amalgamated Amitotic-Mitosis
Loss of Function Genetics
“Death” Recovery Cells
Driver Mutations
Tumor Parasitic Life
Walen, K.H. (2007) Bipolar Genome Reductional Division of Human Near-Senescent, Polyploid Fibroblast Cells. Cancer Genetics and Cytogenetics, 173, 43-50. https://doi.org/10.1016/j.cancergencyto.2006.09.013
Walen, K.H. (2011) Normal Human Cell Conversion to 3-D Cancer-Like Growth: Genome Damage, Endopolyploidy, Senescence Escape, and Cell Polarity Change/Loss. Journal of Cancer Therapy, 2, 181-189. https://doi.org/10.4236/jct.2011.22023
Walen, K.H. (2013) Normal Human Cells Acquiring Proliferative Advantage to Hyperplasia-Like Growth-Morphology: Aberrant Progeny Cells Associated with Endopolyploid and Haploid Divisions. Cancer and Clinical Oncology, 2, 19-33. https://doi.org/10.5539/cco.v2n2p19
Walen, K.H. (1965) Spatial Relationships in the Replication of Chromosomal DNA. Genetics, 51, 915-929.
Walen, K.H. (2012) Genome Reversion Process of Endopolyploidy Confers Chromosome Instability on Descendent Diploid Cells. Cell Biology International, 36, 137-145. https://doi.org/10.1042/CBI20110052
Davoli, T. and de Lange, T. (2011) The Causes and Consequences of Polyploidy in Normal Development and Cancer. Annual Review of Cell and Developmental Biology, 27, 585-610. https://doi.org/10.1146/annurev-cellbio-092910-154234
Walen, K.H. (2013) Senescence Arrest of Endopolyploid Cells Renders Senescence into One Mechanism for Positive Tumorigenesis. In: Hayat, M.A., Ed., Tumor Dormancy and Cellular Quiescence and Senescence, Vol. 1, Springer, Dordrecht, 215-226. https://doi.org/10.1007/978-94-007-5958-9_18
Walen, K.H. (2018) Genomic Instability in Cancer I: DNA-Repair Triggering Primitive Hereditary 4n-Skewed, Amitotic Division-System, the Culprit in EMT/MET/ Metaplasia Cancer Concept. Journal of Cancer Therapy, 9, 974-997. https://doi.org/10.4236/jct.2018.912081
Draviam, V.M., Shapiro, I., Aldridge, B. and Sorger, P.K. (2006) Missorientation and Reduced Stretching of Aligned Sister Kinetochores Promote Chromosome Missegregation in EB1- or APC-Depleted Cells. The EMBO Journal, 25, 2814-2827. https://doi.org/10.1038/sj.emboj.7601168
Fox, D.T. and Duronio, R.J. (2013) Endoreplication and Polyploidy: Insight into Development and Disease. Development, 140, 3-12. https://doi.org/10.1242/dev.080531
Lucchetta, E.M. and Ohlstein, B. (2017) Amitosis of Polyploid Cells Regenerates Functional Stem Cells in Drosophila Intestine. Cell Stem Cell, 20, 609-620. https://doi.org/10.1016/j.stem.2017.02.012
Davoli, T. and de Lange, T. (2012) Telomere-Driven Tetraploidization Occurs in Human Cells Undergoing Crisis and Promotes Transformation of Mouse Cells. Cancer Cell, 21, 765-776. https://doi.org/10.1016/j.ccr.2012.03.044
Gisselsson, D. and Egnell, R. (2017) Cancer—An Insurgence of Clones. Trends in Cancer, 3, 73-75. https://doi.org/10.1016/j.trecan.2016.11.010
Wong, D.J., Paulson, T.G., Prevo, L.J., Galipeau, P.C., Longton, G., et al. (2001) p16INK4a Lesions Are Common, Early Abnormalities That Undergo Clonal Expansion in Barrett’s Metaplastic Epithelium. Cancer Research, 61, 8284-8289.
Dikovskaya, D., Schiffmann, D., Newton, I.P., Oakley, A., Kroboth, K., Sansom, O., et al. (2007) Loss of APC Induces Polyploidy as a Result of a Combination of Defects in Mitosis and Apoptosis. Journal of Cell Biology, 176, 183-195. https://doi.org/10.1083/jcb.200610099
Barrett, M.T., Pritchard, D., Palanca-Wessels, C., Anderson, J., Reid, B.J. and Rabinovitch, P.S. (2003) Molecular Phenotype of Spontaneously Arising 4N (G2-Tetraploid) Intermediates of Neoplastic Progression in Barrett’s Esophagus. Cancer Research, 63, 4211-4217.
Steinbeck, R.G. (2004) Dysplasia in View of the Cell Cycle. European Journal of Histochemistry, 84, 203-211.
Saunders, W.S., Shuster, M., Huang, X., Gharaibe, B., Enyenihi, A.H., Petersen, J. and Gollin, S.M. (2000) Chromosomal Instability and Cytoskeleton Defects in Oral Cancer. Proceedings of the National Academy of Sciences of the United States of America, 97, 303-308. https://doi.org/10.1073/pnas.97.1.303
Walen, K.H. (2015) Wound Healing Is a First Response in a Cancerous Pathway: Hyperplasia Developments to 4n Cell Cycling in Dysplasia Linked to Rb-Inactivation. Journal of Cancer Therapy, 6, 906-916. https://doi.org/10.4236/jct.2015.610099
Weaver, B.A. and Cleveland, D.W. (2006) Does Aneuploidy Cause Cancer? Current Opinion in Cell Biology, 18, 658-667. https://doi.org/10.1016/j.ceb.2006.10.002
Hurst, L.D. and Nurse, P. (1991) A Note on the Evolution of Meiosis. Journal of Theoretical Biology, 150, 561-563. https://doi.org/10.1016/S0022-5193(05)80447-3
Buchsbaum, R. (1951) Animals without Backbones, Vol. 1. Penguin Books, London.
Grell, K.G. and Ruthmann, A. (1964) Uber die Karyologie des Radiolars Aulachanta scolymantha und Feinstruktur seiner Chromosomen. Chromosoma, 15, 185-211. https://doi.org/10.1007/BF00285729
Kuhn, E.M. and Therman, E. (1986) Cytogenetics of Bloom’s Syndrome. Cancer Genetics and Cytogenetics, 22, 1-18. https://doi.org/10.1016/0165-4608(86)90132-9
Bachrati, C.Z. and Hickson, I.D. (2003) RecQ Helicases Suppressors of Tumorigenesis and Premature Aging. Biochemical Journal, 374, 577-606. https://doi.org/10.1042/bj20030491
Walen, K.H. (2017) Mitotic Slippage Process Concealed Cancer-Sought Chromosome Instability Mechanism (S-CIN). Journal of Cancer Therapy, 8, 608-623. https://doi.org/10.4236/jct.2017.86052
Walen, K.H. and Brown, S.W. (1962) Chromosomes in a Marsupial (Potororous tridactylis) Tissue Culture. Nature, 194, 406-408. https://doi.org/10.1038/194406a0
Brenner, S., Branch, A., Meredith, S. and Berns, M.W. (1977) The Absence of Centrioles from Spindle Poles of Rat Kangaroo (PtK-2) Cells. Journal of Cell Biology, 72, 368-379. https://doi.org/10.1083/jcb.72.2.368
Tokheim, C.J., Papadopoulis, N., Kinzler, K.W., Vogelstein, B. and Karchin, R. (2016) Evaluating the Evaluation of Cancer Driver Genes. Proceedings of the National Academy of Sciences of the United States of America, 113, 14330-14335. https://doi.org/10.1073/pnas.1616440113
Storlazzi, C.T., Lonoce, A., Guastadisegni, M.C., Trombetta, D., et al. (2010) Gene Amplification as Double Minutes or Homogeneously Staining Regions in Solid Tumors: Origin and Structure. Genome Research, 20, 1198-1206. https://doi.org/10.1101/gr.106252.110
Davoli, T., Uno, H., Wooten, E.C. and Elledge, S.J. (2017) Tumor Aneuploidy Correlates with Markers of Immune Evasion and with Reduced Response to Immunotherapy. Science, 355, eaaf8399. https://doi.org/10.1126/science.aaf8399
Beroukhlim, R., Mermel, C.H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J.S., Bobson, J., et al. (2010) The Landscape of Somatic Copy Number Alterations across Human Cancers. Nature, 463, 899-905. https://doi.org/10.1038/nature08822
Heim, S. and Mitelman, F. (1995) Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. 2nd Edition, Wiley-Liss, Inc., New York.
Mitelman, F. (1988) Catalog of Chromosome Aberrations in Cancer. Alan Liss, Inc., New York.
Walen, K.H. (2019) Genomic Instability in Cancer II: 4N-Skewed (90°) Reductive Division via Fragile Sites to Fitness Increase for Solid and Hematological Cancer Beginnings. Journal of Cancer Therapy, 19, 537-564. https://doi.org/10.4236/jct.2019.107045
Durkin, S.G. and Glover, T.W. (2007) Chromosome Fragile Sites. Annual Review of Genetics, 41, 169-192. https://doi.org/10.1146/annurev.genet.41.042007.165900
Durkin, S.G., Ragland, R.L., Artl, M.F., Mulle, J.G., Warren, S.T. and Glover, T.W. (2008) Replication Stress Induces Tumor-Like Microdeletions in FHIT/FRA3B. Proceedings of the National Academy of Sciences of the United States of America, 105, 246-251. https://doi.org/10.1073/pnas.0708097105
Royer, C. and Lu, X. (2011) Epithelial Cell Polarity: A Major Gatekeeper against Cancer? Cell Death & Differentiation, 18, 1470-1477. https://doi.org/10.1038/cdd.2011.60
Etienne-Manneville, S. and Hall, A. (2003) Cdc42 Regulates GSK-3β and Adenomatous Polyposis Coli to Control Cell Polarity. Nature, 421, 753-756. https://doi.org/10.1038/nature01423
Nellika, R.K., Dharmapal, D., Sreeja, J.S. and John, R. (2019) α-Fodrin Is Required for Organization of Functional Microtubules during Mitosis. Cell Cycle, 18, 2713-2726. https://doi.org/10.1080/15384101.2019.1656476
Pattabiraman, D.R., Bierie, B., Kober, K.I., Thiru, P., Kraft, J.A., Zill, C., et al. (2016) Activation of PKA Leads to Mesenchymal-to-Epithelial Transition and Loss of Tumor-Initiating Ability. Science, 351, aad3680. https://doi.org/10.1126/science.aad3680
Klymkowsky, M.W. and Savagner, P. (2009) Epithelial-Mesenchymal Transition—A Cancer Researcher’s Conceptual Friend and Foe. The American Journal of Pathology, 174, 1588-1593. https://doi.org/10.2353/ajpath.2009.080545
Dunham, L.J. (1972) Cancer in Man at Site of Prior Benign Lesion of Skin or Mucous Membrane: A Review. Cancer Research, 32, 1359-1374.
Deng, G., Lu, Y., Zlotnikov, G., Thor, A.D. and Smith, H.S. (1996) Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas. Science, 274, 2057-2059. https://doi.org/10.1126/science.274.5295.2057
Jemaa, M., Abdallah, S., Liedo, G., Perrot, G., Lesluyes, T., Teyssier, C., Roux, P., et al. (2017) Heterogeneity in Sarcoma Cell Lines Reveals Enhanced Motility of Tetraploid versus Diploid Cells. Oncotarget, 8, 16669-16689. https://doi.org/10.18632/oncotarget.14291
Erenpreisa, J. and Crag, M.S. (2013) Three Steps to Immortality of Cancer Cells: Senescence, Polyploidy and Self-Renewal. Cancer Cell International, 13, Article No. 92. https://doi.org/10.1186/1475-2867-13-92
Tse, H.T.K., Weaver, W.M. and Carlo, D.D. (2012) Increased Asymmetric and Multi-Daughter Cell Division in Mechanically Confined Microenvironments. PLoS ONE, 7, e38986. https://doi.org/10.1371/journal.pone.0038986
Mirzayans, R., Andrais, B., Kumar, P. and Murray, D. (2016) The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival. International Journal of Molecular Sciences, 17, 708-723. https://doi.org/10.3390/ijms17050708
Wang, Q., Wu, P.C., Dong, D.Z., Ivanova, I., Chu, E., Zeliadi, S., Vesselle, H. and Wu, D.Y. (2013) Polyploidy Road to Therapy-Induced Cellular Senescence and Escape. International Journal of Cancer, 132, 1505-1515. https://doi.org/10.1002/ijc.27810
Roberson, R.S., Kussick, S.J., Vallieres, E., Chen, S.-Y.J. and Wu, D.Y. (2005) Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers. Cancer Research, 65, 2795-2803. https://doi.org/10.1158/0008-5472.CAN-04-1270
Sikora, E., Mosieniak, G. and Sliwinska, M.A. (2016) Morphological and Functional Characteristic of Senescent Cancer Cells. Current Drug Targets, 17, 377-387. https://doi.org/10.2174/1389450116666151019094724
Puig, P.-E., Guilly, M.-N., Bouchot, A., Droin, N., Cathelin, D., Bouyer, F., Favier, L., Ghiringhelli, F., Kroemer, G., Solary, E., Martin, F. and Chauffert, B. (2008) Tumor Cells Can Escape DNA-Damaging Cisplatin through DNA Endoreduplication and Reversible Polyploidy. Cell Biology International, 32, 1031-1043. https://doi.org/10.1016/j.cellbi.2008.04.021
Deberardinis, R.J. and Cheng, T. (2010) Q’s Next: The Diverse Function of Glutamine in Metabolism, Cell Biology and Cancer. Oncogene, 29, 313-324. https://doi.org/10.1038/onc.2009.358
Cantor, J.R. and Sabatini, D.M. (2012) Cancer Cell Metabolism: One Hallmark, Many Faces. Cancer Discovery, 2, 881-898. https://doi.org/10.1158/2159-8290.CD-12-0345
Freed, J.J. and Schatz, S.A. (1969) Chromosome Aberrations in Cultured Cells Deprived of Single Essential Amino Acids. Experimental Cell Research, 55, 393-409. https://doi.org/10.1016/0014-4827(69)90574-6
Cao, Y., Walen, K.H. and Schnurr, D. (1988) Coxsackievirus B-3 Selection of Virus Resistant Buffalo Green Monkey Kidney Cells and Chromosome Analysis of Parental and Resistant Cells. Archives of Virology, 101, 209-219. https://doi.org/10.1007/BF01311002
Janssen, A. and Medena, R.H. (2011) Mitosis as an Anti-Cancer Target. Oncogene, 30, 2799-2809. https://doi.org/10.1038/onc.2011.30
Murga, M., Jaco, I., Fan, Y., Soria, R., Martinez-Pastor, B., Cuadrado, M., et al. (2007) Global Chromatin Compaction Limits the Strength of the DNA Damage Response. Journal of Cell Biology, 178, 1101-1108. https://doi.org/10.1083/jcb.200704140
Shih, I.-M., Zhou, W., Goodman, S.N., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (2001) Evidence That Genetic Instability Occurs at an Early Stage of Colorectal Tumorigenesis. Cancer Research, 61, 818-822.
Kaiser, J. (2018) Is Genome-Guided Cancer Treatment Hyped? Science, 360, 365. https://doi.org/10.1126/science.360.6387.365
Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The Cancer Genome. Nature, 458, 719-724. https://doi.org/10.1038/nature07943
Bignold, L.P., Coghlan, B.L.D. and Jersmann, H.P.A. (2007) David Paul von Hansemann: Contributions to Oncology. Context, Comments, and Translations. Birkhauser Basel, Switzerland.
Kaiser, J. (2012) Cancer Genetics with an Edge. Science, 337, 282-284. https://doi.org/10.1126/science.337.6092.282
Garbe, J.C., Vrba, L., Sputova, K., Fuchs, L., Novak, P., Brothman, A.R., Jackson, M., et al. (2014) Immortalization of Normal Human Mammary Epithelial Cell in Two Steps by Direct Targeting of Senescence Barriers Does Not Require Gross Genomic Alterations. Cell Cycle, 13, 3423-3435. https://doi.org/10.4161/15384101.2014.954456
Amend, S.R., Torga, G., Lin, K.-C., Kosteca, L.G., de Marzo, A., Austin, R.H. and Plenta, K.J. (2019) Polyploid Giant Cancer Cells: Unrecognized Actuators of Tumorigenesis, Metastasis, and Resistance. The Prostate, 79, 1489-1497. https://doi.org/10.1002/pros.23877
Jackson, S.P. and Helleday, T. (2016) Drugging DNA Repair. Science, 352, 1178-1179. https://doi.org/10.1126/science.aab0958
Tomacetti, C., Li, L. and Vogelstein, B. (2017) Stem Cell Divisions, Somatic Mutations, Cancer Etiology, and Cancer Prevention. Science, 355, 1330-1334. https://doi.org/10.1126/science.aaf9011
Nowak, M.A. and Waclaw, B. (2017) Genes, Environment, and “Bad Luck”. Science, 355, 1266-1267. https://doi.org/10.1126/science.aam9746
Adjiri, A. (2017) DNA Mutations May Not Be the Cause of Cancer. Oncology and Therapy, 5, 85-101. https://doi.org/10.1007/s40487-017-0047-1
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
Cairns, J. (1978) Cancer: Science and Society. W. H. Freeman and Company, USA.
Raza, A. (2019) The First Cell: And the Human Costs of Pursuing Cancer to the Last. Hachette Book Group, New York.
Clipponi, A., Goode, D.L., Bedo, J., McCabe, M.J., Pajic, M., Croucher, D.R., et al. (2020) MTOR Signaling Orchestrates Stress-Induced Mutagenesis, Facilitating Adaptive Evolution in Cancer. Science, 368, 1127-1131. https://doi.org/10.1126/science.aau8768